drugset / Trial / NCT00844675
Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is: * To examine if oral administration of Pariet (proton pump inhibitor, 20mg tablets, twice daily for 5 days) before Endoscopic mucosal resection(EMR) exhibits preventive effects of ulcer bleeding compared with placebo group (preoperative administration of placebo) * To evaluate the effects on the suppression of acid secretion of preoperative administration of an Proton pump inhibitor
Timeline
- Start
- 2007-10
- Primary completion
- 2011-12
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 20 mg | Oral |